Research work · 2020

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff Porter Sharman, Miklós Egyed, Wojciech J. Jurczak, Alan Pierre Zausner Skarbnik, John M. Pagel, Ian W. Flinn, Manali Kirtikumar Kamdar, Talha Munir, Renata J. Walewska, Gillian Corbett, Laura Fogliatto, Yair Herishanu, Versha Banerji, Steven E. Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann M. Janssens, Florence Cymbalista

The Lancet

Read free full text

DOI: 10.1016/s0140-6736(20)30262-2